<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-14T21:05:32Z</responseDate><request verb="GetRecord" identifier="oai:uvadoc.uva.es:10324/68984" metadataPrefix="mods">https://uvadoc.uva.es/oai/request</request><GetRecord><record><header><identifier>oai:uvadoc.uva.es:10324/68984</identifier><datestamp>2025-02-07T13:58:48Z</datestamp><setSpec>com_10324_1187</setSpec><setSpec>com_10324_931</setSpec><setSpec>com_10324_894</setSpec><setSpec>col_10324_1408</setSpec></header><metadata><mods:mods xmlns:mods="http://www.loc.gov/mods/v3" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
<mods:name>
<mods:namePart>Parte, Lucía G.</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Fernández, Sergio</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Sandonís, Eva</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>Guerra Navarro, Francisco Javier</mods:namePart>
</mods:name>
<mods:name>
<mods:namePart>López Hernández, Enol</mods:namePart>
</mods:name>
<mods:extension>
<mods:dateAvailable encoding="iso8601">2024-07-22T13:54:34Z</mods:dateAvailable>
</mods:extension>
<mods:extension>
<mods:dateAccessioned encoding="iso8601">2024-07-22T13:54:34Z</mods:dateAccessioned>
</mods:extension>
<mods:originInfo>
<mods:dateIssued encoding="iso8601">2024</mods:dateIssued>
</mods:originInfo>
<mods:identifier type="citation">Marine Drugs, , Mayo, 2024, vol. 22, n. 6, artículo 253</mods:identifier>
<mods:identifier type="uri">https://uvadoc.uva.es/handle/10324/68984</mods:identifier>
<mods:identifier type="doi">10.3390/md22060253</mods:identifier>
<mods:identifier type="publicationfirstpage">253</mods:identifier>
<mods:identifier type="publicationissue">6</mods:identifier>
<mods:identifier type="publicationtitle">Marine Drugs</mods:identifier>
<mods:identifier type="publicationvolume">22</mods:identifier>
<mods:identifier type="essn">1660-3397</mods:identifier>
<mods:abstract>Transition metal catalysis has contributed to the discovery of novel methodologies and&#xd;
 the preparation of natural products, as well as new chances to increase the chemical space in drug&#xd;
 discovery programs. In the case of marine drugs, this strategy has been used to achieve selective,&#xd;
 sustainable and efficient transformations, which cannot be obtained otherwise. In this perspective,&#xd;
 weaimto showcase how a variety of transition metals have provided fruitful couplings in a wide&#xd;
 variety of marine drug-like scaffolds over the past few years, by accelerating the production of these&#xd;
 valuable molecules.</mods:abstract>
<mods:language>
<mods:languageTerm>spa</mods:languageTerm>
</mods:language>
<mods:accessCondition type="useAndReproduction">info:eu-repo/semantics/openAccess</mods:accessCondition>
<mods:accessCondition type="useAndReproduction">MDPI</mods:accessCondition>
<mods:subject>
<mods:topic>Química orgánica</mods:topic>
</mods:subject>
<mods:titleInfo>
<mods:title>Transition-Metal-Catalyzed Transformations for the Synthesis of Marine Drugs</mods:title>
</mods:titleInfo>
<mods:genre>info:eu-repo/semantics/article</mods:genre>
</mods:mods></metadata></record></GetRecord></OAI-PMH>